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Driving Innovation:
How Stronger Laws Pull Safer Chemicals into the Market
By Baskut Tuncak*

N

Introduction

o one can deny that many of the features of modern life
owe much to the ingenuity of the chemical industry.
New chemicals, new applications for existing chemicals, and new chemical processes enabled a host of innovations
across a range of industries and led to the growth of the chemical industry over the past several decades. Since the 1970s, the
output of the chemical industry has grown from approximately
US$ 1 trillion adjusted for inflation to US$ 4.12 trillion in 2010,
with estimates for 2020 approaching US$ 6.5 trillion.1 As the
scale of the chemical industry has grown so too has evidence
of the adverse effects of chemicals on human health and the
environment.
Innovation is especially relevant today as the establishment
of the chemical industry, from manufacturers to formulators,
face increasing pressure from two fronts.2 First, after overtaking
traditional leaders such as the United States and Western Europe
in bulk chemical manufacturing, emerging economies are positioning themselves to become leaders in chemical innovation.3
Simultaneously, the chemical industry is also facing increasing
pressure from downstream users, retailers, and consumers to
provide safer products through the development and use of safer
chemicals.
A common refrain by the regulated (or soon-to-be regulated) industry is that stricter laws over hazardous chemicals will
impede innovation, reducing economic growth, competitiveness,
and employment. We define “laws” to include legislation, regulation, directives, decisions, rules, and other forms of enforceable standards at the sub-national, national, regional, and global
level. Current laws in the European Union and United States
designed to protect people and the environment from hazardous
chemicals aim to enhance innovation.4 However, both European
and American laws have shortcomings in terms of their ability
to prevent harm, the costs of which are borne by individuals and
society-at-large, and to encourage the entry of safer alternatives.
Can stricter laws over hazardous chemicals drive innovation?
Can it drive innovation while also sending it in a safer direction?
Reviewing recent measures to reduce the risk of harm from
additives to plastics (phthalates), toxic flame retardant chemicals (“PBDEs”), refrigerants (“CFCs”), and pesticides (methyl
bromide), this article focuses on the features of policies that
stimulated innovation and the factors that led to satisfactory or
unsatisfactory outcomes. Examining patents as an indication of
rates of invention, this article explores the types of inventions
that downstream users and consumers in the market subsequently adopted.
4

This article presents findings regarding the efficacy of past
measures and the potential of stricter laws to accelerate innovation toward safer chemicals. First, the article presents findings
on the human health effects of hazardous chemicals, illustrating
the pressing need for innovation around safer chemicals. The
next section discusses the rate at which alternatives are invented
in response to the prospect of stricter laws. Then, the article
examines the types of inventions adopted by downstream users
after regulators take measures, exploring why the transition may
or may not have been to safer alternatives. Fourth, the article
looks at how the law can help safer alternatives overcome barriers to entry, enabling early adopters to gain competitive advantage through innovation and an opportunity to optimize their
return on new investments. The final section presents findings
on how stricter laws direct resources to the innovation of safer
alternatives.

Human Health Effects Linked to
Hazardous Chemicals
As the scale of the chemical industry has grown since the
1970s so too has evidence of the adverse effects of chemicals on
human health and the environment. According to Eurostat, the
share of toxic chemicals in the total production of chemicals is at
62%.5 Analyses of household cleaners, plastic products (including toys), clothing, and other everyday products show that many
such products can contain over seventy chemicals considered of
very high concern.6 Recent biomonitoring studies confirm the
migration of hundreds of hazardous chemicals from everyday
products into people, either directly, or through food, water, air,
household dust, and other sources.7 Of significant concern is the
exposure of children to a potent cocktail of hazardous chemicals
during critical windows of development. These exposures occur
through their mother’s womb and breast milk, as well as from
broader environmental sources mentioned above. The effects of
exposure to these chemicals at an early age often do not manifest
for many years or even decades.
There is an increasing incidence of many diseases around
the world, including many that were much less prevalent in children in decades past. These trends include:
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• A 24% increase of childhood cancers such as leukemia and
brain cancer since 1975 and a forty percent increase in the
incidence of breast cancer between 1973 and 1998;8
• Asthma, which approximately doubled in prevalence
between 1980 and 1995, continues to rise;9
• Forty percent more women reported difficulty conceiving
and maintaining a pregnancy from 1982 to 2002. From 1982
to 1995, the incidence of reported difficulty almost doubled
in younger women, ages 18–25;10
• Sharp increases in male genital malformations;11
• Learning and developmental disabilities, including autism
and attention deficit hyperactivity disorder, affect nearly one
in six U.S. children, as of 2008;12
• Doubling of the rate of diabetes in the United States and
England, with increasing frequency among young populations;13 and
• Dramatic rise in the prevalence of obesity among both older
and younger populations, and both wealthy, industrialized
countries as well as poorer developing countries.14
There is growing consensus about the role of chemicals in
the increasing incidence of many disorders around the world.
Among many factors, there is increasing evidence that exposure
to endocrine disrupting chemicals (“EDCs”) at an early age is
linked to many of these disorders.15
An EDC is a chemical, or mixture of chemicals, that interferes with any aspect of hormone action.16 Suspected EDCs are
commonly found in people, wildlife, and the environment. Over
800 chemicals have been identified as having endocrine disrupting properties.17 All of the twenty-two chemicals listed under
the Stockholm Convention, a global treaty that restricts or bans
some of the most hazardous chemicals used around the world,
have endocrine disrupting properties.18
The adverse effects that are increasingly linked to exposure to chemicals with endocrine disrupting properties include:
effects on reproduction, such as infertility and reduced sperm
count and viability; breast, mammary, testicular, and prostate
cancers; type 2 diabetes, obesity, and heart disease; neurobehavioral outcomes; and thyroid and immune system dysfunction.19
There are several key features of endocrine disrupting
chemicals that make exposure to any dose of an EDC unsafe,
including effects at low doses,20 cumulative effects,21 permanent
adverse effects during critical developmental windows,22 effects
on future generations,23 and ubiquity in the environment.24

Stricter Chemical Laws Spark the
Invention of Alternatives
A common argument against the prospect of stricter rules
to protect people and the environment from hazardous chemicals is that there is not a viable alternative to the chemical.25
This argument might be made for technical reasons, such as the
“performance” of the chemical relative to alternatives, or the
lack of manufacturing capacity for alternatives. It can also be
made for economic reasons, where an alternative is argued to be
prohibitively expensive. Restricting or banning the chemical of
concern would, the argument goes, reduce the competitiveness
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of a product or may even result in the unavailability of a product
or process from the market altogether. The argument is essentially a threat of lost profits, jobs, and competitiveness at the
global level.26
These arguments, however, ignore our ability to invent better solutions and re-design the way people interact with their
environment. This section reviews chemicals of concern, ranging
from industrial chemicals in consumer products to pesticides,
under national, regional, and global environmental laws. Review
was limited to chemicals that have sufficient information about
their hazardous properties and are subject to significant scrutiny
in more than one region of the world. In each case, the prospect
of stricter rules for certain chemicals sparked the invention and
development of alternatives, including incremental improvements in the performance of pre-existing alternatives.27 Stricter
laws are defined as those that: (a) require a significant reduction in exposure to hazardous chemicals; (b) require compliance through the use of comparatively costly technology; or (c)
require significant technological change.28 Below are findings
for two chemicals or classes of chemicals of concern that also
clearly illustrate this trend: phthalates, a widely used endocrine
disrupting chemical; and chlorofluorocarbons, an ozone depleting substance.

Phthalates
Phthalates are a class of chemicals used as plasticizers to
soften certain plastics. Ninety percent of phthalate production,
estimated to be in the millions of tons per year, is used to plasticize polyvinyl chloride (“PVC”).29 As a plasticizer, phthalates
are not bound to the plastic polymer, so they leach out of products, resulting in exposure for people and wildlife and contaminating homes and the environment.30 Phthalates are also used as
solvents in many cosmetics that are applied directly to the skin,
including perfumes, lotions, soaps, shampoos, deodorants, and
hair care products.
Certain phthalates are widely recognized as EDCs. Some
disturbing genital deformations associated with phthalate exposure in animals have earned the title of “phthalate syndrome.”31
Other potential adverse effects include cancer, obesity, diabetes,
and attention deficit hyperactivity disorder.32 Like other EDCs,
these effects are believed to correlate with exposure during
critical windows of development. Recent studies have detected
phthalate metabolites in a high percentage of people tested.
Some cases found phthalate metabolites in all urine samples
analyzed.33
Beginning in 1998, following European leadership, countries
around the world took measures to protect human health from
certain hazardous phthalates. In addition to the Member States
of the European Union (“EU”), Canada, Japan, Iceland, Mexico,
Norway, Argentina, Tunisia, and the United States are among the
many countries that took measures to ban or restrict the use of
certain phthalates. The EU added four of these phthalates (BBP,
DEHP, DBP, and DIBP) to the EU’s REACH Candidate List, and
subsequently the REACH Authorization List.34 Through their
inclusion on the Authorization List, all uses of these phthalates
5

in the EU are required to cease by February 21, 2015, unless
for a specifically authorized use.35 Certain Member States of the
EU continue to pursue more stringent domestic measures than
measures at the regional level.36
These measures may have sparked the invention of alternatives to certain uses of phthalates. Publicly available patent
records illustrate a surge of inventions (measured by “patent
families”) to eliminate exposure to phthalates. There is a noticeable acceleration in the filing of patents, and thus the pace of
invention, beginning around 1999, following the initial EU measures, and accelerating again in 2006, around the adoption of
REACH. These time points correlate with years in which Europe
led the world in adopting measures to reduce the use of certain
phthalates.

others significantly increased their patenting of alternatives.
Nearly one-half of the patented inventions claiming an alternative to phthalates reference the health and environmental concerns surrounding this class of chemicals.

Figure 2. Stricter Laws Trigger Innovation by Major Chemical
Manufacturers.

Figure 1. Spike in Patented Inventions Free of Hazardous
Phthalates.

Considering the varying degree of research and development required before filing a patent, inventors likely foresaw the
enactment of stricter laws and began research necessary for the
patent application beforehand, filing when new laws appeared
imminent to maximize their time-period of exclusivity under the
patent.37 Because these events took place long before compliance
deadlines, companies were afforded the necessary lead-time to
develop and possibly patent their technological inventions. For
example, the EU’s temporary directive in 1999 was proceeded
by a Recommendation by the European Commission in July
1998, which itself was preceded by an opinion of the European
Commission’s Scientific Committee on Toxicity, Ecotoxicity,
and the Environment in April 1998.38
The correlation of increased invention in response to the
prospect of stricter laws is consistent with other lessons of the
past. For example, investigations of regulatory events surrounding lead, mercury, polychlorinated biphenyls (“PCBs”), and
vinyl chloride also confirm that informal regulatory procedures
before rulemaking began drove companies to develop their technological responses.39
Yet it was not until significantly strict measures appeared
likely (inclusion in the Authorization List under the EU’s
“REACH” Regulation) that major chemical manufacturers and
6

Following Evaluation of the information provided, an EU
Member State or the European Chemical Agency (“ECHA”)
may propose to identify a chemical as a Substance of Very High
Concern (“SVHCs”)40 and place it on the REACH “Candidate
List.” Subsequently, ECHA can recommend a chemical on
the Candidate List for Authorization. If approved by the
European Commission, the chemical is placed on the REACH
Authorization List, in which case companies must request authorization for specified uses after a “Sunset Date.”
According to the European Commission’s interim evaluation of the impact of REACH on innovation in Europe (“REACH
Innovation Report”), “the Candidate List is a, if not the, major
driver for change at present.”41 As more information about the
intrinsic hazards of chemicals within the scope of REACH
becomes available, the Candidate List stands to continue to
drive innovation in the chemical industry.42 With broad criteria
for identifying endocrine disrupting chemicals and information
about endocrine disrupting properties of chemicals, it stands to
reason that the Candidate List will further drive innovation.

CFCs
Chlorofluorocarbons (“CFCs”) displaced ammonia, sulfur
dioxide, carbon dioxide, and other “natural” refrigerants in
the 1930s. Unlike these refrigerants, countries adopted CFCs
because they offered a safer alternative in terms of their toxicity,
flammability, and/or energy efficiency.43 Unfortunately, it was
not until many decades later that these chemicals were widely
acknowledged to be ozone depleting substances.44 Other uses
for CFCs included foam production (e.g. Styrofoam™), aerosol
products, and solvents for cleaning products with delicate components such as electronics.
Chemical companies were alert to the human health and
environmental consequences of CFC emissions as early as 1972.
Following a 1972 conference, DuPont and other CFC manufacturers formed a consortium coordinated by what is now the
American Chemistry Council (“ACC”), a U.S. trade association
for chemical manufacturers.45 When ozone depletion resulting
from CFC emissions began to gain substantial mainstream attention in 1974, members of the consortium defended the continued
Sustainable Development Law & Policy

Table 1. Intrinsic properties of various chemical refrigerants.

Chemical

Ozone depleting potential
(relative to CFC-11)

Global warming potential Other hazardous properties
(relative to CO2)

Ammonia*

0

< 1 Highly toxic (but odor enables evacuation),
slightly flammable

Carbon Dioxide*

0

CFC-11

1

4,600

CFC-12

0.820

10,600

HCFC-22

0.034

1700

HFC-134a

0

1300

Hydrocarbons*

0

1 Toxic at high doses

~20 Flammable

*“Natural” refrigerants53
use of CFCs, and called for additional scientific evidence, insisting their chemicals were safe until proven otherwise. They also
argued that health and wealth would decline in a world without
CFC products.46
Simultaneously, research and development into alternatives
was well underway, with several alternatives identified. During
debate over stricter measures on CFCs and other ozone depleting
substances, representatives of DuPont and other CFC manufacturers stated that they had identified technically viable alternatives to CFCs between 1975 and 1980 but could not introduce
these alternatives because, by their estimates, the alternatives
would not be economically viable.47 Later, these manufacturers
acknowledged that it was the lack of legally-enforceable standards that prevented the entry of safer alternatives.48
The United States, Canada, Sweden, and Norway announced
plans to ban non-essential aerosol products in 1976, aided in part
by slumping sales of CFC-containing products due to consumer
concern. These laws at the national level spurred changes in the
industry, most notably in the United States. Changes in the U.S.
industry in turn positioned the United States well to push more
actively for international laws over ozone depleting substances,
given its own competitive advantage.49
In 1987, countries around the world agreed on a timeline
for the global phase out of CFCs under the Montreal Protocol.50
A patent search by the World Intellectual Property Organization
showed that various chemical manufacturers and other diversified businesses in both Japan and the United States patented a
variety of processes, including the process for the manufacture
of one of the most widely used alternatives to CFCs, hydrofluorocarbon (HFC)-134a, in 1987 and 1988.51
Thus, the prospect of stricter laws at the national and global
level spurred inventors to research alternatives to CFCs and
hydrochlorofluorocarbons (“HCFCs”), leading to the development of both HFCs and inventions for the safer use of “natural”
refrigerants (used in the 1930s before CFCs) as alternatives
to CFC refrigerants.54 HFCs prevailed over ammonia, carbon
dioxide (“CO2”), and other “natural” refrigerants due to the
cost advantages. However, while HFCs are not ozone depleting
substances, they are potent greenhouse gasses. Aided by stricter
rules in Europe that phased out HFCs in new cars after 2011
Summer 2014

Figure 3. Innovation
Cycle of Refrigerants.
Innovation of various
chemical refrigerants over the 20th and
21st centuries. Dates
are approximations
based on major usage
and expected reductions under national
and international
agreements.52

and public campaigns to use hydrocarbons in domestic refrigerators, considerable research and development continued around
the use of natural refrigerants.55 Incremental inventions enabled
these “natural” refrigerants to overcome properties deemed
undesirable almost a century ago (see Table 1). With the continued development of natural refrigerants, hydrocarbon domestic
refrigerators are now economically viable and commonly available in Europe and Asia, with both environmentalists and manufacturers alike advocating for the United States to adopt them as
well.56 In addition, suppliers of equipment using ammonia rather
than HCFCs recaptured market share in cold storage and food
freezing.57
The prospect of progressively stricter laws over CFCs and
other ozone depleting substances sparked the continuous invention of alternatives, including improved methods of using natural
refrigerants, making the chemicals once displaced by CFCs a
viable alternative to ozone depleting substances and greenhouse
gasses.58 Together, the experiences of both phthalates and CFCs
illustrate how the systematic introduction of progressively
stricter rules at the global and regional levels spurred the continuous invention of safer chemicals, averting the serious consequences of inaction and disproving the estimated cost of action.

Chemical Laws Can—But Not Always Do—
Pull Safer Inventions Into the Market
For quite some time I have been confronted with problems
from the plasticizers in vinyl for aerospace applications and I
7

have long since come to the conclusion that vinyl should not
be permitted in any phase of aerospace usage . . . . [S]ubstitute
polymers for the vinyl are readily available and in many cases
they have far superior physical properties at a small sacrifice in
immediate cost.
—Frederick G. Gross, NASA Materials
Engineering Branch, April 26, 197159
Innovation hinges on the adoption of an invention. As
illustrated above, chemical laws can accelerate the invention
of alternatives to hazardous chemicals. To replace widely used
hazardous chemicals, inventors created new chemicals and processes, developed new uses for existing chemicals, and found
alternative approaches. The spike in invention to eliminate certain phthalates shows that environmental laws can be a critical
element—a driver—in accelerating invention in the chemical
industry.
Chemical laws can also pull inventions into the market,
thereby turning invention into innovation. The above examples
of CFCs and phthalates illustrate this. Some of the alternatives
used for certain phthalates and CFCs existed well-before the
prospect of stricter laws was on the horizon. Until the prospect
of enacting stricter restrictions on the use of these entrenched
and hazardous chemicals, companies sidelined these alternatives, with far less opportunity for adoption in the market and
further development through experience gained from their successes and shortcomings.
Some of the replacements for chemicals of concern,
however, have been very unsatisfying. History is replete with
examples of regrettable substitution, where years of concerted
effort is undertaken to restrict or phase-out an individual chemical of concern, only to see the chemical replaced with a different
chemical of concern.60 This unsatisfying transition has undermined the confidence of the public and businesses in the ability
of innovation alone to ensure meaningful progress towards safer
alternatives. Below, is a cross-section of examples of substitution, ranging from clearly regrettable substitutes, to the entry of
alternatives that raise questions, and finally, to more promising
examples.

Regrettable Substitution
Over the last several decades, demand for chemical flameretardants has accelerated. Production increased from just over
500 million pounds in 1983, to 3.4 billion pounds in 2009, and
projections expect it to jump another 30% to 4.4 billion pounds
by 2014.61 The transition away from toxic flame-retardants provides one example for regrettable substitution.
Polychlorinated biphenyls (“PCBs”) and polybrominated
biphenyls (“PBBs”) were widely used as flame-retardants until
the 1970s, when health and environmental concerns began to surface.62 When PCBs and PBBs were banned as flame-retardants,
polybrominated diphenyl ethers (“PBDEs”) took their place in
the market as flame-retardants. Under U.S. and European laws at
the time, PBDEs were considered “existing” chemicals, meaning no evidence of safety was required for these chemicals to
remain on the market when industrial chemical laws were passed
8

in the 1970s in the United States and Europe.63 Production and
use increased rapidly for PBDEs over the next several decades
as new markets for them emerged, or were created, including
furniture foam, electronics, textiles, and baby products.64
Overwhelming evidence has emerged about the hazards of
PBDEs, including their endocrine disrupting properties.65 Not
only do these chemicals exhibit toxicity at both high and lowdoses, but they persist in the environment rather than breaking
down into safer constituents, accumulate in living organisms,
and travel long distances by wind, water, animals in which
they have accumulated, and products traded internationally. As
evidence of the dangers of PBDEs grew overwhelming, many
countries around the world began to phase out certain PBDEs,
creating the possibility for the entry of safer alternatives.66 In
other countries, manufacturers of PBDEs agreed to voluntarily
discontinue the production and sale of these chemicals. The
Stockholm Convention, a global treaty that applies to some
of the world’s most hazardous chemicals, banned two types of
PBDEs in 2009.67 PBDEs are one example of regrettable substitution among a cluster of toxic flame-retardants.
Unfortunately, one of the replacements for certain PBDEs
is yet another episode of regrettable substitution. The U.S.
Environmental Protection Agency (“EPA”) approved Firemaster
550™, a mixture of several chemicals, in 2003 under the U.S.
Toxic Substances Control Act’s (“TSCA”) provisions for the
approval of new chemicals.68 Because of the limited power for
regulators to demand sufficient proof of safety before companies produce a new chemical for use, the EPA could only use
the scant information provided by the manufacturer, Chemtura,
and computer models to predict the chemical mixture’s toxicity.
According to a U.S. EPA official, “[w]e didn’t think [Firemaster
550™] would bioaccumulate, but it turns out that prediction
isn’t borne out by reality.”69
Regulators in the United States approved Firemaster 550™
for use, even though it had suspicions, including the structural
similarity of a chemical ingredient of Firemaster 550™ to
DEHP, a phthalate restricted from certain uses due to evidence
that it is a reproductive toxin. U.S. authorities asked Chemtura
to provide additional studies. Chemtura provided two of its own
studies, five years later, which showed adverse effects at highdoses, such as skeletal malformations and low-birth weight. But
the company argued that these results were inconclusive.70
Although advertised as a “green” replacement to PBDEs,71
evidence continues to emerge that one or more ingredients of
Firemaster 550™ are released from products containing the mixture, could be toxic, accumulate in wildlife, travel long-distances
through the environment, and may have adverse effects at low
doses.72 Like PBDEs and structurally similar phthalates, recent
studies indicate that some of Firemaster 550™'s ingredients
have endocrine disrupting properties.73 Yet Firemaster 550™
remains in use.

More Promising Examples of Substitution
Chemists have discovered ways to design chemicals to
make them inherently safer. An older example is the ability to
Sustainable Development Law & Policy

design chemicals so that they do not persist as long in the environment.74 One such technique is the use of secondary nitrogen
atoms instead of tertiary nitrogen atoms to enhance biodegradability, as demonstrated with the use of ethylenediamine-N,N’disuccinic acid (“EDDS”) instead of ethylenediaminetetraacetic
acid (EDTA) as a complexing agent. Complexing agents like
EDTA can be used to improve cleaning efficiency by sequestering metals in water-based solutions, but they also raise concerns
about their ability to mobilize toxic metals in the environment.75
Some countries and regions have phased out EDTA for certain
applications.76 EDDS is far more biodegradable than EDTA and
also performs better as a complexing agent in some applications.
With the increasing stringency of measures on the use of
certain phthalates, including the scheduled phase out of four
phthalates (DEHP, DBP, BBP, and DIBP) from certain products
in the European Union by February 21, 2015, alternatives are
increasingly being demonstrated as viable and adopted.77 While
some phthalate-based alternatives raise questions, other alternatives to phthalates show more promise.
For example, experiments with different types of raw materials as feedstocks have resulted in a castor-oil-based alternative
to phthalate plasticizers for PVC (Soft-n-Safe™). It has been
approved for use in food contact surfaces, vinyl flooring and
wallpaper, toys, medical devices, inks, textile dyes, and other
applications.78 This direct substitute does not exhibit many
of the intrinsic hazards of phthalates and other plasticizers.
Notably, and unlike the phthalates they replace, studies show no
evidence of endocrine disruption or other adverse effects for this
alternative.79
In the effort to remove phthalates from products, other companies have removed a principle reason phthalates are used in the
first place—PVC. For example, office products retailer Staples®
removed PVC from its packaging materials.80 Downstream
users are also removing phthalates by removing the PVC. Of
particular concern is the use of phthalate-containing PVC for
blood bags and other infusion/transfusion sets, which can subject very young children to hazardous levels of the phthalate
DEHP during critical windows of development. As a result of
recent measures for particular phthalates, medical suppliers that
provide phthalate-free alternatives to PVC medical devices are
experiencing a boom in both demand and growth.81
Innovators have also found safer alternatives to treating
furniture foam with toxic chemicals to prevent furniture fires.
For example, specially designed upholstery can resist smoldering cigarettes, preventing underlying foam from igniting. In
addition, researchers developed non-toxic fire-resistant barriers,
adopted by mattress manufacturers. Both of these alternatives
are far more effective at slowing fire than adding flame retardants
to foam, which in fact does not slow the fire by any significant
degree according to several tests by government agencies and
independent laboratories.82
The above examples illustrate how invention has been
sparked by laws to reduce or eliminate hazardous chemicals.
First-movers may have a considerable advantage over competitors as demand and requirements for safer products increase.
Summer 2014

Requirements for Stricter Chemicals Laws
Legal controls cleared the way for the adoption of alternatives, pulling newly developed or pre-existing solutions to occupy
the space vacated by certain hazardous chemicals. In order to
increase the likelihood that safer alternatives will be pulled into
the market, the law needs to clearly identify hazardous properties
that are not acceptable in society and require their substitution
with safer alternatives (including non-chemical alternatives) in
a systematic way. For example, the EU’s REACH authorization
procedure gives a clear signal to industry that chemicals that are
carcinogens, mutagens, or toxic to reproduction, and those that
exhibit persistence and bioaccumulation, need to be substituted
with safer alternatives.83 This provides clear direction to chemical manufacturers and downstream users of chemicals that they
must innovate away from chemicals with these properties.
The availability of information about chemical hazards and
the prospect of regulatory action accelerate research towards
safer solutions, whether it is through the invention of new chemicals, new applications of existing chemicals, new materials, or
new processes.84 But more critically, stricter requirements that
chemical manufacturers generate information about intrinsic
hazards and exposures can drive innovation in a safer direction.
Without information about the full scope of intrinsic hazards of
all chemicals, downstream businesses are highly vulnerable to
investing in the substitution of one hazardous chemical with a
different hazardous chemical. Some might say they risk jumping
from the frying pan into the fire.
The surge in the invention of alternatives to phthalates
began the same time as European laws limited the use of six
widely used phthalates in toys and other children’s products,
a small percentage of global phthalate use.85 To some degree,
both the number of phthalates and the number of products within
the scope of laws around the world are increasing and stand to
increase further as the deadline for authorization of uses for
certain phthalates approaches in the EU.86 This trend towards
stricter laws over the use of phthalates spurred the invention of
phthalate alternatives beyond the miniscule share of the market
occupied by toys and children’s products.87
The ability of chemical laws to pull inventions into the
market is a crucial aspect of the potential power of chemicals
policies to spur innovation toward safer alternatives. Businesses
may argue that environmental laws follow the invention of alternatives to hazardous chemicals and thus are not a driver of innovation. But it is the prospect of stricter measures that often drives
the research and development of new ideas and later enables the
entry of these ideas into the market.88 The acceleration in the
number of non-phthalate and phthalate-free patents illustrates
how the prospect of progressively stricter rules against the use
of hazardous chemicals can incentivize, or push, companies to
develop alternatives (see Figures 1 and 2).
Part of this ability comes from the power of the law to enable
new ideas, safer alternatives in this case, to overcome barriers
to entry. Even if a safer alternative to a chemical of concern is
invented and available for adoption, there are many factors that
present barriers to its entry into the market.
9

One factor is the substantial economies of scale for existing chemicals.89 These economies of scale result not only from
the economies inherent in higher production volumes but also
from long periods in which innovations could occur around their
production and use, with resulting increases in efficiencies and
demand.90 The discovery of new uses, increasing production
volumes and the development of more efficient processes for
chemical synthesis enable existing chemicals to become more
and more entrenched in products and processes.
Second, the continued externalization of costs by the chemical industry makes it difficult for safer alternatives to compete
on a level playing field.91 Externalities are costs or benefits
arising from an economic activity that affect somebody other
than the people engaged in the economic activity and are not
reflected fully in prices.92 Recent analyses by the United Nations
Environment Programme (“UNEP”) highlight the cost of inaction for the sound management of chemicals on human health
and the environment, with large burdens falling on individuals
and government budgets. These reports conclude that, “the vast
majority of human health costs of chemical production, consumption and disposal are not borne by chemical producers, or
shared down the value-chain. Uncompensated harm to human
health and the environment are market failures that need to be
corrected.”93
A third factor is an inability of businesses, consumers, and
regulators to access information about the hazards of chemicals
and products containing hazardous chemicals.94 The vast majority of chemicals lack adequate information about their adverse
effects, such as their potential for endocrine disruption.95 This is
due in large part to chemical policies adopted around the world
in the 1970s that presumed the safety of nearly all chemicals
in commerce. Policies have changed in Europe and elsewhere
to require basic information on the most widely used industrial
chemicals. For example, 72% of businesses surveyed responded
that REACH had led to increased access to information about
chemicals.96 Small firms benefited more than larger firms in
terms of conception of products resulting from increased information enabled by REACH, in particular information about
hazardous substances communicated along the supply chain
(through Safety Data Sheets).97
Despite information generated to date under REACH, the
ongoing dearth of information remains a concern. As information is generated in the coming years for “existing” lower production volume chemicals, the benefits of information generated
by REACH for innovation is likely to grow.98
Stricter chemical laws can help to pull inventions into the
market. But, safer chemicals will continue to face an uphill battle in displacing hazardous chemicals as long as: (1) economies
of scale are not addressed; (2) the costs of hazardous chemicals
remain externalized to the public; and (3) information asymmetries continue to exist. Effective chemical laws can and must
address these factors, enabling the adoption of safer chemicals
and thus innovation towards safer products and processes.
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Stricter Chemicals Laws Direct Resources
Toward Innovation and the Development of
Safer Alternatives
It is argued that strict regulation entails unnecessary costs
to the regulated industry and hampers the introduction of certain
inventions. Ideally, inventions not allowed onto the market would
be those that are dangerous to human health or the environment
or are otherwise undesirable. Achieving the appropriate balance
between measures to protect human health and the environment
on the one hand, and the freedom to experiment and develop
better solutions to problems on the other, is something most
stakeholders can agree upon, although where this balance lies is
at the center of many contentious debates.
Responding to a survey commissioned by the European
Commission about the impacts of EU REACH on innovation,
some businesses claimed that there has been a significant redirection of skilled personnel from R&D and innovation-related
activities to compliance work as a result of the implementation
of the regulation.99 But since the 1970s, scholars have questioned
the notion that stricter laws direct resources away from R&D and
innovation-related activities.100 Scholars conclude from these
studies that, “innovation is indeed being changed by regulation,
but that there is a redirection of innovative efforts into more
socially approved areas, rather than an absolute decline.”101
Overall, responses tended to reflect the European Commission’s
Economic Impact Analysis: negative effects of having to meet
compliance requirements could dominate in the short term, with
significant positive impacts on innovation expected in the longer
term.102
Other findings of the independent survey suggest that, in
fact, more resources have been directed towards innovation as
a result of the EU’s REACH Regulation. For example, regarding the impact of REACH on innovation, nearly half of survey
respondents report that as a result there has been an increase in
expenditure on research and development (“R&D”) and related
innovative activities.103 Two reasons were suggested for this
increase: the inability to stop innovation programs that were of
strategic importance to the firms in question, and—most significantly—the creation of new opportunities due to the coming into
force of the REACH Regulation.104
Of concern during debates over the possible impact of
REACH’s requirements was the impact of the Regulation on
innovation by small and medium-sized enterprises (“SMEs”).
Notably, small, medium and large businesses were all among
those reporting an increase in expenditure on R&D in response
to the stricter requirements of REACH.105
In short, regarding the overall effect of mechanisms within
REACH on the willingness and determination of businesses to
innovate, the REACH Innovation Report concludes that despite
having to bear the additional costs of REACH, firms have continued to innovate and are keen to continue to do so.106
Moreover, some of the responses illuminate the potential
for the creation of new, highly specialized jobs. As information comes due for submission for an increasing number
of chemicals under REACH, it is believed that demand for
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human resources with technical and regulatory expertise will
increase.107 Universities responded to this new demand by
developing chemistry curricula with a specialization in REACH.
The authors of the REACH innovation report conclude that as a
result of REACH, “it is envisaged that over time the number and
quality . . . of skilled human resources to industry will increase
and be supportive of innovative activity.”108
The above patent findings also support the conclusion that
stricter rules for chemical safety can drive greater resources
towards invention and innovation. The above-mentioned acceleration in the number of patents claiming phthalate-alternative
or phthalate-free invention is one indication of an increase in
resources towards invention and innovation. Indeed, the most
active companies are some of the biggest manufacturers of
phthalates—Exxon Mobil, Dow, and Eastman Kodak/Eastman
Chemical (see Figure 2). In addition to these three large chemical
manufacturers, the study found that eighty-five other companies
obtained at least one patent for a “non-phthalate” or “phthalatefree” invention.
The most common phthalate measure restricts six phthalates
above a certain concentration in toys and children’s products.
However, the study found that approximately 95% of the patents
identified were not limited to infant and children’s products.
Moreover, inventions were disclosed for the use of phthalates in
a range of products, much broader than the limited market segment singled out under the law.109 These patent filings suggest
that as the likelihood of stricter rules over existing chemicals
of concern increased, resources were devoted to innovation to
maintain or even capture market share.
Thus, while some may argue that stricter rules for ensuring chemical safety may direct resources away from innovation,

recent experiences suggest that the desire to maintain market
share by industry is sufficient to direct resources towards the
innovation of safer alternatives and the development of new,
innovation-friendly skills.

Conclusion
Consumers, downstream users, and investors are increasingly demanding products free of hazardous chemicals throughout their life-cycle. In addition to customer demand, businesses
increasingly recognize that the transition away from hazardous
chemicals is often accompanied by the emergence of a competitive advantage and market opportunities. Effective chemical
policies must be in place to reward businesses that develop safer
approaches by enabling their ideas to replace those that are less
safe.
The question is then how to spur the innovation of approaches
that stand to provide the most improvement to people, wildlife,
and the environment from the status quo of chemicals. And then,
for those inventions that are indeed a safer alternative, how to
effectively overcome barriers to entry so that these safer alternatives can displace incumbent hazardous chemicals and production processes in the marketplace.
The findings of this study suggest that progressively stricter
laws, with a gradual phase-out of chemicals with certain intrinsic hazards, spur the innovation of alternatives, with the potential to pull safer alternatives into the market, enabling them to
overcome barriers to entry. This enables innovators that seek
comparative advantages to continuously innovate towards the
safest alternative for various uses and allows predictability for
industry and investors. 
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